Amylin Pharmaceuticals to Webcast First Quarter Results
April 09 2007 - 5:05PM
PR Newswire (US)
SAN DIEGO, April 9 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Quarterly
Update Conference Call for the first quarter of 2007 on Monday,
April 16, 2007 at 8:30 a.m. ET/5:30 a.m. PT. Daniel M. Bradbury,
Amylin's President and Chief Executive Officer, will lead the call.
On the same date premarket, Amylin will release financial results
for the first quarter of 2007. The call will be webcast live
through Amylin's corporate website and a recording will be made
available following the close of the call. To access the webcast,
please log on to http://www.amylin.com/ approximately fifteen
minutes prior to the call to register, download and install any
necessary audio software. For those without access to the Internet,
the live call may be accessed by phone by calling (866) 362-4832
(domestic) or (617) 597-5364 (international), passcode 71295475. A
replay of the call will also be available by phone for 24 hours
beginning approximately one hour after the close of the call and
can be accessed at (888) 286-8010 (domestic) or (617) 801-6888
(international), passcode 81236977. About Amylin Amylin
Pharmaceuticals is a biopharmaceutical company committed to
improving lives through the discovery, development and
commercialization of innovative medicines. Amylin has developed and
gained approval for two first- in-class medicines for diabetes,
SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)
injection. Amylin's research and development activities leverage
the company's expertise in metabolism to develop potential
therapies to treat diabetes and obesity. Amylin is located in San
Diego, California with over 1600 employees nationwide. Further
information on Amylin Pharmaceuticals and its pipeline in
metabolism is available at http://www.amylin.com/. DATASOURCE:
Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive
Director, Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024